Article
Recent advances in the epidemiology, diagnosis and control of diseases caused by porcine circovirus type 2.
Centre de Recerca en Sanitat Animal (CReSA), UAB-IRTA, Campus de la Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
The Veterinary Journal (impact factor:
2.24).
03/2010;
187(1):23-32.
DOI:10.1016/j.tvjl.2010.01.018
pp.23-32
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition.
[show abstract] [hide abstract]
ABSTRACT: Porcine circovirus associated disease (PCVAD) encompasses a group of syndromes linked to infection with porcine circovirus type 2 (PCV2). Based on the hypothesis that the immune responses to vaccination versus infection are quantitatively and qualitatively different, the objective of this study was to evaluate immunity, virus replication and disease protection in pigs vaccinated with PCV2 capsid protein (CP) and during infection. The disease model included dual infection with PCV2 and porcine reproductive and respiratory syndrome virus (PRRSV), a virus known to enhance disease progression and severity. The principal effect of PRRSV infection was to increase peak PCV2 viremia by almost 40-fold; however, PCV2 failed to show a reciprocal effect on PRRSV. In vaccinated pigs, there was no evidence of disease or PCV2 replication following dual virus challenge. Immunity following vaccination favored PCV2 neutralizing activity; whereas, PCV2 infection and disease produced high levels of non-neutralizing antibody, primarily directed against a polypeptide in the C-terminal region of CP. These results support the notion that the magnitude of the total antibody response cannot be used as a measure of protective immunity. Furthermore, protection versus disease lies in the immunodominance of specific epitopes. Epitope specificity should be taken into consideration when designing PCV2 vaccines.Vaccine 04/2012; 30(27):4079-85. · 3.77 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
causal agent
excellent tool
histopathological examination
immune
immune modulation
lymphoid tissue
management factors
multifactorial 'triggers'
PCV2
PCV2 infection
PCV2 vaccines
pig production
PMWS
porcine circovirus type 2
porcine circovirus-related diseases
Post-weaning multisystemic wasting syndrome
quantitative PCR techniques
recent commercial availability
review assesses recent advances
sow